Hannover Re US partners with GalenusRx
Hannover Life Reassurance Company of America and Hannover Life Reassurance Company of America announced a “first of its kind” cooperation agreement with GalenusRx, which looks to help people avoid preventable morbidity and mortality from their medication regimens.
GalenusRx’s medication safety technology gives patients and providers the knowledge they need to prevent adverse drug events and promote better health outcomes. APPRAISETM, GalenusRx’s proprietary platform, analyzes drug-drug, multi-drug, drug-gene, and drug disease interactions to provide a comprehensive risk assessment, individualized down to the DNA to identify risks, then translates results to clear levels of concern.
GalenusRx’s technology and consulting service, Lifesaving Insights, provides a comprehensive understanding of how every patient’s body responds to medication, with personalized assessments and tailored recommendations from Precision Clinical Pharmacists. Together, these solutions point the way toward efficacy and safety — with optimized medication regimens, reduced polypharmacy, and lowered medical expenses.
The insurer will offer GalenusRx’s technology and services to its healthcare clients through their brokers and consultants.
“We are delighted to partner with GalenusRx to offer its technology and services to our healthcare clients through their brokers and consultants. We believe that GalenusRx will help avoid the harmful effects of taking multiple drugs and reduce insured losses. Through this partnership with GalenusRx, Hannover Re US will support its healthcare clients to improve quality and outcomes. Clients participating in accountable care and other value-based programs will also generate additional savings and will benefit from reduced total medical expenditures through GalenusRx method of avoiding predictable ADEs, thus improving their bottom line while providing better care for their policyholders.” – Julian Whitekus, VP, Health Solutions, Hannover Re US.
“GalenusRx engages eligible members in a completely different way than they have experienced in the past regarding their medication safety, enhancing the customer journey. We are proud to start an expansive partnership with Hannover Re US that enhances the member experience while supporting healthcare organizations to meet their clinical, economic, and humanistic goals. Through this collaboration, we are demonstrating the unique value proposition of GalenusRx and supporting the provider-pharmacist collaboration in a novel way to improve outcomes.” – Peter Panageas, Chief Commercial Officer, GalenusRx.
